Asset Allocation

As of March 31, 2026.
Type % Net
Cash 3.04%
Stock 58.63%
Bond 31.69%
Convertible 0.00%
Preferred 4.18%
Other 2.46%
View Asset Allocation
Start Trial

Market Capitalization

As of March 31, 2026
Large 78.80%
Mid 17.87%
Small 3.33%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 98.78%    % Emerging Markets: 0.40%    % Unidentified Markets: 0.82%

Americas 98.42%
96.14%
Canada 90.12%
United States 6.02%
2.28%
Chile 0.02%
As of March 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 0.71%
United Kingdom 0.62%
0.09%
Denmark 0.00%
France 0.02%
Germany 0.05%
Greece 0.00%
Ireland 0.00%
Italy 0.00%
Netherlands 0.02%
Spain 0.00%
0.00%
0.00%
Greater Asia 0.05%
Japan 0.02%
0.00%
Australia 0.00%
0.03%
Singapore 0.03%
0.00%
Unidentified Region 0.82%

Bond Credit Quality Exposure

AAA 17.79%
AA 15.08%
A 16.89%
BBB 21.31%
BB 13.07%
B 4.87%
Below B 0.20%
    CCC 0.20%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.04%
Not Available 10.75%
Short Term 0.00%
As of March 31, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
40.10%
Materials
1.07%
Consumer Discretionary
4.06%
Financials
31.77%
Real Estate
3.20%
Sensitive
32.80%
Communication Services
1.62%
Energy
14.99%
Industrials
14.61%
Information Technology
1.58%
Defensive
9.87%
Consumer Staples
5.57%
Health Care
0.00%
Utilities
4.30%
Not Classified
17.23%
Non Classified Equity
4.82%
Not Classified - Non Equity
12.41%
As of March 31, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of March 31, 2026
Type % Net
Government 21.09%
Corporate 48.59%
Securitized 0.01%
Municipal 23.72%
Other 6.59%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
6.02%
Less than 1 Year
6.02%
Intermediate
54.10%
1 to 3 Years
10.68%
3 to 5 Years
15.72%
5 to 10 Years
27.70%
Long Term
37.46%
10 to 20 Years
11.39%
20 to 30 Years
14.65%
Over 30 Years
11.42%
Other
2.42%
As of March 31, 2026
View Bond Maturity Exposure
Start Trial